Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AGIO |
---|---|---|
09:32 ET | 1703 | 33.45 |
09:36 ET | 200 | 33.59 |
09:38 ET | 100 | 33.58 |
09:39 ET | 1462 | 33.64 |
09:41 ET | 7900 | 33.63 |
09:45 ET | 417 | 33.685 |
09:48 ET | 1392 | 33.745 |
09:50 ET | 300 | 33.76 |
09:52 ET | 1452 | 33.865 |
09:54 ET | 483 | 33.89 |
09:56 ET | 200 | 33.885 |
09:59 ET | 607 | 33.79 |
10:01 ET | 200 | 33.68 |
10:03 ET | 100 | 33.68 |
10:06 ET | 1163 | 33.635 |
10:08 ET | 200 | 33.66 |
10:12 ET | 566 | 33.69 |
10:17 ET | 100 | 33.73 |
10:19 ET | 200 | 33.68 |
10:21 ET | 800 | 33.72 |
10:24 ET | 200 | 33.73 |
10:30 ET | 300 | 33.69 |
10:32 ET | 700 | 33.7 |
10:33 ET | 100 | 33.7 |
10:35 ET | 200 | 33.78 |
10:39 ET | 100 | 33.725 |
10:42 ET | 200 | 33.68 |
10:46 ET | 1100 | 33.645 |
10:48 ET | 100 | 33.65 |
10:50 ET | 2400 | 33.515 |
10:51 ET | 200 | 33.43 |
10:55 ET | 126 | 33.455 |
10:57 ET | 1200 | 33.49 |
11:00 ET | 100 | 33.43 |
11:02 ET | 615 | 33.425 |
11:04 ET | 600 | 33.43 |
11:06 ET | 400 | 33.43 |
11:08 ET | 200 | 33.415 |
11:09 ET | 900 | 33.465 |
11:11 ET | 400 | 33.48 |
11:13 ET | 4000 | 33.375 |
11:15 ET | 300 | 33.3 |
11:18 ET | 100 | 33.26 |
11:22 ET | 502 | 33.245 |
11:24 ET | 1200 | 33.32 |
11:26 ET | 500 | 33.265 |
11:27 ET | 2859 | 33.29 |
11:29 ET | 100 | 33.315 |
11:31 ET | 500 | 33.305 |
11:33 ET | 400 | 33.34 |
11:38 ET | 100 | 33.43 |
11:40 ET | 100 | 33.49 |
11:42 ET | 500 | 33.4 |
11:44 ET | 10300 | 33.4 |
11:45 ET | 500 | 33.31 |
11:47 ET | 1100 | 33.245 |
11:49 ET | 10900 | 33.31 |
11:51 ET | 700 | 33.27 |
11:54 ET | 200 | 33.27 |
11:56 ET | 400 | 33.225 |
11:58 ET | 300 | 33.25 |
12:00 ET | 800 | 33.25 |
12:02 ET | 300 | 33.26 |
12:03 ET | 300 | 33.355 |
12:05 ET | 408 | 33.35 |
12:07 ET | 100 | 33.32 |
12:09 ET | 300 | 33.39 |
12:12 ET | 1442 | 33.44 |
12:14 ET | 6436 | 33.5 |
12:16 ET | 400 | 33.52 |
12:18 ET | 400 | 33.59 |
12:20 ET | 1219 | 33.475 |
12:21 ET | 100 | 33.475 |
12:23 ET | 900 | 33.605 |
12:25 ET | 5908 | 33.6 |
12:32 ET | 200 | 33.52 |
12:34 ET | 200 | 33.55 |
12:36 ET | 300 | 33.58 |
12:38 ET | 613 | 33.62 |
12:39 ET | 204 | 33.64 |
12:41 ET | 100 | 33.63 |
12:43 ET | 908 | 33.7 |
12:45 ET | 500 | 33.7 |
12:48 ET | 5004 | 33.77 |
12:50 ET | 5728 | 33.67 |
12:52 ET | 1700 | 33.665 |
12:54 ET | 3710 | 33.675 |
12:56 ET | 1519 | 33.715 |
12:57 ET | 600 | 33.69 |
12:59 ET | 620 | 33.66 |
01:01 ET | 957 | 33.645 |
01:03 ET | 404 | 33.7 |
01:06 ET | 8349 | 33.68 |
01:08 ET | 400 | 33.715 |
01:10 ET | 500 | 33.68 |
01:12 ET | 4925 | 33.595 |
01:14 ET | 1835 | 33.635 |
01:15 ET | 500 | 33.63 |
01:17 ET | 1300 | 33.615 |
01:19 ET | 732 | 33.62 |
01:24 ET | 7401 | 33.545 |
01:26 ET | 6548 | 33.485 |
01:28 ET | 1450 | 33.48 |
01:30 ET | 1629 | 33.43 |
01:32 ET | 1000 | 33.5 |
01:33 ET | 1080 | 33.49 |
01:35 ET | 1100 | 33.53 |
01:37 ET | 2000 | 33.47 |
01:39 ET | 1825 | 33.42 |
01:42 ET | 1100 | 33.46 |
01:44 ET | 2593 | 33.435 |
01:46 ET | 5572 | 33.37 |
01:48 ET | 1142 | 33.38 |
01:50 ET | 2500 | 33.37 |
01:51 ET | 630 | 33.35 |
01:53 ET | 600 | 33.34 |
01:55 ET | 200 | 33.355 |
01:57 ET | 500 | 33.27 |
02:00 ET | 1013 | 33.28 |
02:02 ET | 2640 | 33.285 |
02:04 ET | 1826 | 33.28 |
02:06 ET | 1547 | 33.36 |
02:08 ET | 600 | 33.355 |
02:09 ET | 300 | 33.355 |
02:11 ET | 1100 | 33.345 |
02:13 ET | 800 | 33.32 |
02:15 ET | 1120 | 33.345 |
02:18 ET | 1729 | 33.38 |
02:20 ET | 4076 | 33.34 |
02:22 ET | 600 | 33.3 |
02:24 ET | 819 | 33.27 |
02:26 ET | 1100 | 33.34 |
02:27 ET | 2545 | 33.3 |
02:29 ET | 600 | 33.29 |
02:31 ET | 705 | 33.26 |
02:33 ET | 900 | 33.27 |
02:36 ET | 955 | 33.3132 |
02:38 ET | 1600 | 33.24 |
02:40 ET | 100 | 33.24 |
02:42 ET | 6436 | 33.23 |
02:44 ET | 9663 | 33.17 |
02:45 ET | 200 | 33.19 |
02:47 ET | 905 | 33.23 |
02:49 ET | 100 | 33.29 |
02:51 ET | 300 | 33.29 |
02:54 ET | 200 | 33.295 |
02:56 ET | 630 | 33.3075 |
02:58 ET | 300 | 33.305 |
03:00 ET | 800 | 33.375 |
03:02 ET | 1361 | 33.4 |
03:03 ET | 2404 | 33.44 |
03:05 ET | 200 | 33.44 |
03:07 ET | 500 | 33.46 |
03:09 ET | 200 | 33.5 |
03:12 ET | 513 | 33.455 |
03:14 ET | 372 | 33.445 |
03:16 ET | 1614 | 33.465 |
03:18 ET | 1525 | 33.43 |
03:20 ET | 1496 | 33.33 |
03:21 ET | 1400 | 33.38 |
03:23 ET | 4645 | 33.32 |
03:25 ET | 300 | 33.325 |
03:27 ET | 100 | 33.325 |
03:30 ET | 2830 | 33.34 |
03:32 ET | 1587 | 33.35 |
03:34 ET | 4111 | 33.445 |
03:36 ET | 319 | 33.39 |
03:38 ET | 400 | 33.36 |
03:39 ET | 1224 | 33.37 |
03:41 ET | 3175 | 33.345 |
03:43 ET | 1851 | 33.305 |
03:45 ET | 5356 | 33.37 |
03:48 ET | 4651 | 33.315 |
03:50 ET | 4440 | 33.28 |
03:52 ET | 9496 | 33.345 |
03:54 ET | 12770 | 33.295 |
03:56 ET | 10306 | 33.41 |
03:57 ET | 14912 | 33.375 |
03:59 ET | 173790 | 33.44 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Agios Pharmaceuticals Inc | 1.9B | -5.3x | --- |
CG Oncology Inc | 1.9B | -27.3x | --- |
NewAmsterdam Pharma Company NV | 1.8B | -7.3x | --- |
Fusion Pharmaceuticals Inc | 1.8B | -15.2x | --- |
Sana Biotechnology Inc | 1.8B | -5.4x | --- |
Keros Therapeutics Inc | 1.8B | -9.9x | --- |
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of alpha- and beta- thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.9B |
---|---|
Revenue (TTM) | $29.4M |
Shares Outstanding | 56.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.75 |
EPS | $-6.31 |
Book Value | $14.50 |
P/E Ratio | -5.3x |
Price/Sales (TTM) | 65.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,336.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.